Ironvine Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-14,818
Closed -$2.44M 60
2021
Q1
$2.44M Hold
14,818
0.28% 45
2020
Q4
$2.33M Hold
14,818
0.29% 43
2020
Q3
$2.21M Hold
14,818
0.28% 41
2020
Q2
$2.08M Hold
14,818
0.28% 41
2020
Q1
$1.94M Buy
14,818
+3,406
+30% +$483K 0.3% 41
2019
Q4
$1.67M Hold
11,412
0.23% 46
2019
Q3
$1.46M Sell
11,412
-155
-1% -$20.4K 0.21% 47
2019
Q2
$1.5M Sell
11,567
-172
-1% -$23.8K 0.25% 46
2019
Q1
$1.64M Sell
11,739
-76,257
-87% -$10.2M 0.31% 45
2018
Q4
$11.4M Buy
87,996
+11,949
+16% +$1.67M 2.31% 23
2018
Q3
$10.5M Buy
76,047
+647
+0.9% +$86K 2.15% 22
2018
Q2
$9.15M Buy
75,400
+2,149
+3% +$268K 2.05% 22
2018
Q1
$9.39M Buy
73,251
+20,834
+40% +$2.82M 2.26% 16
2017
Q4
$7.32M Buy
+52,417
New +$7.3M 2.28% 17

Other funds holding JNJ

Ironvine Capital Partners's JNJ Position: Q2 2021 in Review

Ironvine Capital Partners sold out of Johnson & Johnson (JNJ) in Q2 2021, closing a stake of 14,818 shares — an estimated $2.44M sold.

Ironvine Capital Partners first reported a position in JNJ in Q4 2017 and held it in 14 quarters. The position peaked at $11.4M in Q4 2018. 3,324 funds tracked by Wall St. Rank hold JNJ as of Q2 2021.

  • Ironvine Capital Partners reported no remaining Johnson & Johnson position as of Q2 2021 after selling out during the quarter.
  • Ironvine Capital Partners sold 14,818 Johnson & Johnson shares in Q2 2021, an estimated $2.44M.
  • Ironvine Capital Partners first reported a position in Johnson & Johnson in Q4 2017 and held it in 14 quarters.
  • Ironvine Capital Partners's Johnson & Johnson position peaked at $11.4M in Q4 2018.
  • 3,324 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2021.

Based on Ironvine Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.